Search Blog
Categories
June 2017
M T W T F S S
« May    
 1234
567891011
12131415161718
19202122232425
2627282930  

Tags

Archive for 'ACCESSWIRE'

Daily Coverage on Basic Materials Stocks: McEwen Mining, Sandstorm Gold, Turquoise Hill Resources, and Dundee Precious Metals

By Pro-Trader Daily LONDON, UK / ACCESSWIRE / June 26, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Metals & Mining industry and that trades on the Toronto Exchanges. This Morning, our team […]

Earnings Highlights and Review: Michaels’ GAAP EPS Grew 12%

By Pro-Trader Daily Research Desk Line-up: Finish Line Post Earnings Coverage LONDON, UK / ACCESSWIRE / June 26, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on The Michaels Cos., Inc. (NASDAQ: MIK) (“Michaels”), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=MIK, following the Company’s disclosure of its first quarter fiscal 2017 […]

Halozyme FDA Action Date, Q1 Review, Analysts Outlook and Price Targets

By Traders News Source NEW YORK, NY / ACCESSWIRE / June 26, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report with no obligation on Halozyme Therapeutics (NASDAQ: HALO), a biotechnology company focused on developing and commercializing oncology […]

Investor Network: Naspers Limited Class N to Host Earnings Call

By Investor Network NEW YORK, NY / ACCESSWIRE / June 26, 2017 / Naspers Limited Class N (OTC PINK: NPSNY) will be discussing their earnings results in their Q3 Earnings Call to be held June 26, 2017 at 9:00 AM Eastern Time. To listen to the event live – visit https://www.investornetwork.com/company/18614. Replay Information The replay […]

Oxis Agrees to Acquire Georgetown Translational Pharmaceuticals, Appoints New Chief Executive Officer and Chief Medical Officer

By Oxis International, Inc. LOS ANGELES, CA / ACCESSWIRE / June 26, 2017 / Oxis International Inc. (OTCQB: OXIS) and (Euronext Paris: OXI.PA) announced today that it has executed a binding LOI agreement to acquire Georgetown Translational Pharmaceuticals, Inc. (GTP), a deal that will add new management and a class of close-to-market Central Nervous Systems […]

Featured Company News – Medtronic Announced a 7% EPS Growth; Counted its 40th Bullish Dividend

By Pro-Trader Daily Research Desk Line-up: MGC Diagnostics Post Earnings Coverage LONDON, UK / ACCESSWIRE / June 26, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Medtronic PLC (NYSE: MDT), following which we have published a free report that can be viewed by signing up […]

Featured Company News – Synchronoss Technologies Confirms Unsolicited Acquisition Offer from Siris Capital

By Pro-Trader Daily Research Desk Line-up: Bazaarvoice Post Earnings Coverage LONDON, UK / ACCESSWIRE / June 26, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Synchronoss Technologies Inc. (NASDAQ: SNCR), following which we have published a free report that can be viewed by signing up […]

Featured Company News – Thermo Fisher’s Companion Diagnostic Test to Screen Multiple Non-Small Cell Lung Cancer Gets Pre-market Approval from US FDA

By Pro-Trader Daily Research Desk Line-up: China Cord Blood Post Earnings Coverage LONDON, UK / ACCESSWIRE / June 26, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Thermo Fisher Scientific Inc. (NYSE: TMO), following which we have published a free report that can be viewed […]

CorMedix Inc. Appoints Mehmood Khan, M.D. and Steven Lefkowitz to its Board of Directors

By Cormedix, Inc. Gary Gelbfish, M.D. Appointed as Observer to the Company’s Board of Directors by Elliott Management BEDMINSTER, NJ / ACCESSWIRE / June 26, 2017 / CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced the […]

Theralase Researcher Granted Second US Patent for Novel Anti-Cancer Drugs

By Theralase Technologies Inc. TORONTO, ON / ACCESSWIRE / June 26, 2017 / Theralase Technologies Inc. (“Theralase®” or the “Company“) (TSXV: TLT) (OTCQX: TLTFF), a leading biotechnology company focused on the commercialization of medical devices to eliminate pain and the development of Photo Dynamic Compounds (“PDCs“) to destroy cancer is pleased to announce that the […]